Shandong Sinobioway Biomedicine Co., Ltd. 002581.SZ Stock
Shandong Sinobioway Biomedicine Co., Ltd. Price Chart
Shandong Sinobioway Biomedicine Co., Ltd. 002581.SZ Financial and Trading Overview
Contents
- Shandong Sinobioway Biomedicine Co., Ltd. Price Chart
- Shandong Sinobioway Biomedicine Co., Ltd. 002581.SZ Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Shandong Sinobioway Biomedicine Co., Ltd.
- Q&A For Shandong Sinobioway Biomedicine Co., Ltd. Stock
Shandong Sinobioway Biomedicine Co., Ltd. stock price | 13.12 CNY |
Previous Close | 18.07 CNY |
Open | 18.05 CNY |
Bid | 18.06 CNY x 0 |
Ask | 18.07 CNY x 0 |
Day's Range | 17.97 - 18.44 CNY |
52 Week Range | 13.81 - 21.69 CNY |
Volume | 3.19M CNY |
Avg. Volume | 8.3M CNY |
Market Cap | 11.91B CNY |
Beta (5Y Monthly) | 0.184246 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.08 CNY |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | June 21, 2016 |
1y Target Est | N/A |
002581.SZ Valuation Measures
Enterprise Value | 12.05B CNY |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 34.506145 |
Price/Book (mrq) | 5.0659184 |
Enterprise Value/Revenue | 34.907 |
Enterprise Value/EBITDA | -118.097 |
Trading Information
Shandong Sinobioway Biomedicine Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.184246 |
52-Week Change | 6.79% |
S&P500 52-Week Change | 20.43% |
52 Week High | 21.69 CNY |
52 Week Low | 13.81 CNY |
50-Day Moving Average | 18.79 CNY |
200-Day Moving Average | 16.89 CNY |
002581.SZ Share Statistics
Avg. Volume (3 month) | 8.3M CNY |
Avg. Daily Volume (10-Days) | 5.57M CNY |
Shares Outstanding | 659.74M |
Float | 455.05M |
Short Ratio | N/A |
% Held by Insiders | 43.41% |
% Held by Institutions | 1.55% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 20:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -11.013% |
Operating Margin (ttm) | -48.75% |
Gross Margin | 81.77% |
EBITDA Margin | -29.55% |
Management Effectiveness
Return on Assets (ttm) | -3.81% |
Return on Equity (ttm) | -1.098% |
Income Statement
Revenue (ttm) | 345.3M CNY |
Revenue Per Share (ttm) | 0.52 CNY |
Quarterly Revenue Growth (yoy) | -13.50% |
Gross Profit (ttm) | 280.87M CNY |
EBITDA | -102061056 CNY |
Net Income Avi to Common (ttm) | -38030320 CNY |
Diluted EPS (ttm) | -0.06 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 111.07M CNY |
Total Cash Per Share (mrq) | 0.17 CNY |
Total Debt (mrq) | 148.47M CNY |
Total Debt/Equity (mrq) | 6.07 CNY |
Current Ratio (mrq) | 1.383 |
Book Value Per Share (mrq) | 3.565 |
Cash Flow Statement
Operating Cash Flow (ttm) | -46115224 CNY |
Levered Free Cash Flow (ttm) | 38.53M CNY |
Profile of Shandong Sinobioway Biomedicine Co., Ltd.
Country | China |
State | N/A |
City | Beijing |
Address | Peking University Biological City |
ZIP | 100085 |
Phone | 86 10 8289 9370 |
Website | https://www.sinobiowaymed.com.cn |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 666 |
Shandong Sinobioway Biomedicine Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates in China. The company manufactures and supplies trimethyl orthoformate, triethyl orthoformate, trimethyl orthoacetate, phosphorous acid, ethyl formate, and trimethyl acetate and its by-products. It also offers Enjingfu, a mouse nerve growth factor for injection; Anfulong, a recombinant human interferon a 2b injection; Jiefu, a recombinant human interferon a 2b spray; Bellafort, a combined hepatitis A and B vaccine; Anerlifu, a preservative-free influenza virus split vaccine; Paneraifu.1, an influenza A H1N1 vaccine; and Yierlifu, an inactivated enterovirus 71 vaccine. In addition, the company exports its products. Shandong Sinobioway Biomedicine Co., Ltd. was founded in 2000 and is based in Beijing, China.
Q&A For Shandong Sinobioway Biomedicine Co., Ltd. Stock
What is a current 002581.SZ stock price?
Shandong Sinobioway Biomedicine Co., Ltd. 002581.SZ stock price today per share is 13.12 CNY.
How to purchase Shandong Sinobioway Biomedicine Co., Ltd. stock?
You can buy 002581.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shandong Sinobioway Biomedicine Co., Ltd.?
The stock symbol or ticker of Shandong Sinobioway Biomedicine Co., Ltd. is 002581.SZ.
Which industry does the Shandong Sinobioway Biomedicine Co., Ltd. company belong to?
The Shandong Sinobioway Biomedicine Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Shandong Sinobioway Biomedicine Co., Ltd. have in circulation?
The max supply of Shandong Sinobioway Biomedicine Co., Ltd. shares is 659.74M.
What is Shandong Sinobioway Biomedicine Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Shandong Sinobioway Biomedicine Co., Ltd. PE Ratio is now.
What was Shandong Sinobioway Biomedicine Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Shandong Sinobioway Biomedicine Co., Ltd. EPS is -0.08 CNY over the trailing 12 months.
Which sector does the Shandong Sinobioway Biomedicine Co., Ltd. company belong to?
The Shandong Sinobioway Biomedicine Co., Ltd. sector is Healthcare.